BIVRX vs. SPY
Compare and contrast key facts about Invenomic Fund (BIVRX) and SPDR S&P 500 ETF (SPY).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIVRX or SPY.
Correlation
The correlation between BIVRX and SPY is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BIVRX vs. SPY - Performance Comparison
Key characteristics
BIVRX:
-0.87
SPY:
2.05
BIVRX:
-1.20
SPY:
2.73
BIVRX:
0.87
SPY:
1.38
BIVRX:
-0.32
SPY:
3.07
BIVRX:
-1.09
SPY:
13.22
BIVRX:
9.92%
SPY:
1.95%
BIVRX:
12.47%
SPY:
12.57%
BIVRX:
-34.31%
SPY:
-55.19%
BIVRX:
-30.90%
SPY:
-2.69%
Returns By Period
In the year-to-date period, BIVRX achieves a -1.00% return, which is significantly lower than SPY's 0.58% return.
BIVRX
-1.00%
-0.40%
4.31%
-10.03%
9.71%
N/A
SPY
0.58%
-2.18%
5.70%
25.99%
14.36%
13.16%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. SPY - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than SPY's 0.09% expense ratio.
Risk-Adjusted Performance
BIVRX vs. SPY — Risk-Adjusted Performance Rank
BIVRX
SPY
BIVRX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIVRX vs. SPY - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 3.59%, more than SPY's 1.20% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 3.59% | 3.55% | 2.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.20% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
BIVRX vs. SPY - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -34.31%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BIVRX and SPY. For additional features, visit the drawdowns tool.
Volatility
BIVRX vs. SPY - Volatility Comparison
The current volatility for Invenomic Fund (BIVRX) is 4.01%, while SPDR S&P 500 ETF (SPY) has a volatility of 4.49%. This indicates that BIVRX experiences smaller price fluctuations and is considered to be less risky than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.